ClinicalTrials.gg
Drug

Olezarsen clinical trials

Also written ISIS 678354 and AKCEA-APOCIII-LRx.

studies test it
13
open now
1
in phase 3
8
first study started
2007

How each study uses olezarsen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the olezarsen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Dec 2024 · TRYNGOLZA (AUTOINJECTOR) · NDA 218614 (FDA, Drugs@FDA)
European Union
17 Sept 2025 · Tryngolza · EMEA/H/C/006477 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Olezarsen
10
Cyclosporine Capsules USP (Modified) 100 mg
2
Cyclosporine Capsule
2
Gengraf Capsule
2
Sandimmune Capsule
2

Development codes

ISIS 678354
11
AKCEA-APOCIII-LRx
7

Studies by the year they started

13 studies that test it; most in 2022 (6)

Studies that test olezarsen, by start year
YearStudies
20072
20181
20201
20212
20226
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
2
Phase 3
8
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 0

Ionis Pharmaceuticals, Inc. (10) · Panacea Biotec Ltd (2) · Akcea Therapeutics (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 2 in phase 3

Studies that test olezarsen, phase 3 first.

Studies

Open first, then newest update. How each study uses olezarsen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Codes

What other systems call olezarsen · ClinicalTrials.gg INT002102

  • MeSH (NLM) C000731151olezarsenConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) S3RS2SA30LOLEZARSENConfirmed FDA, NLM
  • NCI Thesaurus C180652OlezarsenOne source FDA

Also registered as olezarsen sodium (UNII NSY2BY6PSB).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.